INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.66B / 21S · 14 late87 trades$28.40M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELL
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 16
7 insiders$7.38M
  • SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  • BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  • SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  • SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

    • Form 4 transactions

    18,956 records
    Side
    allbuysell
    Score
    any≥ 30≥ 50≥ 70
    Sort
    Newest disclosedNewest executedInsider ScoreValue
    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    32
    IN
    Intrator Michael NDirector, CEO and President, 10% Owner
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$1.11M
    14.9K sh
    		Nov 19, 2025Nov 21, 2025
    Page 449 of 474
    ← PrevNext →
    traded Nov 19, 2025
    +2d
    SEC Form 4

    Evidence

    32
    HC
    Hauger CarolynDirector
    VFFVillage Farms International, Inc.
    Open-market sale
    		SELL$83K
    22.0K sh
    		Nov 20, 2025Nov 21, 2025
    traded Nov 20, 2025
    		+1dSEC Form 4

    Evidence

    32
    LM
    Lo Steve MingChief Accounting Officer
    REALTheRealReal, Inc.
    Open-market sale
    		SELL$27K
    2,068 sh
    		Nov 21, 2025Nov 21, 2025
    traded Nov 21, 2025
    		+0dSEC Form 4

    Evidence

    31
    LW
    Lloyd George W.EVP, Investments & CLO
    RPRXRoyalty Pharma plc
    Open-market sale · 10b5-1 plan
    		SELL$1.83M
    47.8K sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    31
    LW
    Lloyd George W.EVP, Investments & CLO
    RPRXRoyalty Pharma plc
    Open-market sale · 10b5-1 plan
    		SELL$1.81M
    47.4K sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    31
    DV
    Date Rajeev VDirector
    CRCLCircle Internet Group, Inc.
    Open-market sale
    		SELL$142K
    2,000 sh
    		Nov 20, 2025Nov 21, 2025
    traded Nov 20, 2025
    		+1dSEC Form 4

    Evidence

    31
    CP
    Clune Katherine PatriciaChief Financial Officer
    PIPRPIPER SANDLER COMPANIES
    Open-market sale
    		SELL$444K
    1,367 sh
    		Nov 21, 2025Nov 21, 2025
    traded Nov 21, 2025
    		+0dSEC Form 4

    Evidence

    30
    HJ
    Holstein JensDirector
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$299K
    7,049 sh
    		Nov 20, 2025Nov 21, 2025
    traded Nov 20, 2025
    		+1dSEC Form 4

    Evidence

    30
    DV
    Date Rajeev VDirector
    CRCLCircle Internet Group, Inc.
    Open-market sale
    		SELL$354K
    5,000 sh
    		Nov 20, 2025Nov 21, 2025
    traded Nov 20, 2025
    		+1dSEC Form 4

    Evidence

    29
    IN
    Intrator Michael NDirector, CEO and President, 10% Owner
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$545K
    7,220 sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    29
    IN
    Intrator Michael NDirector, CEO and President, 10% Owner
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$530K
    7,203 sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    29
    SJ
    Slattery Paul JosephGENERAL COUNSEL & SECRETARY
    BSLKBolt Projects Holdings, Inc.
    Open-market sale
    		SELL$1,360
    819 sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    28
    LW
    Lloyd George W.EVP, Investments & CLO
    RPRXRoyalty Pharma plc
    Open-market sale · 10b5-1 plan
    		SELL$977K
    25.5K sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    28
    EA
    Eltoukhy AdamSEE REMARKS
    IOTSamsara Inc.
    Open-market sale · 10b5-1 plan
    		SELL$53K
    1,447 sh
    		Nov 20, 2025Nov 21, 2025
    traded Nov 20, 2025
    		+1dSEC Form 4

    Evidence

    28
    EA
    Eltoukhy AdamSEE REMARKS
    IOTSamsara Inc.
    Open-market sale · 10b5-1 plan
    		SELL$96K
    2,720 sh
    		Nov 20, 2025Nov 21, 2025
    traded Nov 20, 2025
    		+1dSEC Form 4

    Evidence

    28
    GM
    Gloria MelanieChief Operating Officer
    IMVTImmunovant, Inc.
    Open-market sale
    		SELL$241K
    10.3K sh
    		Nov 20, 2025Nov 21, 2025
    traded Nov 20, 2025
    		+1dSEC Form 4

    Evidence

    27
    PA
    Pinto ArunChief Risk Officer
    SOFISoFi Technologies, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$1.14M
    46.1K sh
    		Nov 21, 2025Nov 21, 2025
    traded Nov 21, 2025
    		+0dSEC Form 4

    Evidence

    27
    HJ
    Holstein JensDirector
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$63K
    1,460 sh
    		Nov 20, 2025Nov 21, 2025
    traded Nov 20, 2025
    		+1dSEC Form 4

    Evidence

    26
    IN
    Intrator Michael NDirector, CEO and President, 10% Owner
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$222K
    2,912 sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    25
    EA
    Eltoukhy AdamSEE REMARKS
    IOTSamsara Inc.
    Open-market sale · 10b5-1 plan
    		SELL$22K
    600 sh
    		Nov 20, 2025Nov 21, 2025
    traded Nov 20, 2025
    		+1dSEC Form 4

    Evidence

    25
    LW
    Lloyd George W.EVP, Investments & CLO
    RPRXRoyalty Pharma plc
    Open-market sale · 10b5-1 plan
    		SELL$106K
    2,770 sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    25
    LW
    Lloyd George W.EVP, Investments & CLO
    RPRXRoyalty Pharma plc
    Open-market sale · 10b5-1 plan
    		SELL$179K
    4,599 sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    25
    LW
    Lloyd George W.EVP, Investments & CLO
    RPRXRoyalty Pharma plc
    Open-market sale · 10b5-1 plan
    		SELL$96K
    2,470 sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    24
    GM
    Gloria MelanieChief Operating Officer
    IMVTImmunovant, Inc.
    Open-market sale
    		SELL$57K
    2,375 sh
    		Nov 20, 2025Nov 21, 2025
    traded Nov 20, 2025
    		+1dSEC Form 4

    Evidence

    24
    YE
    Young William ERetired Director
    SMBCSOUTHERN MISSOURI BANCORP, INC.
    Open-market sale
    		SELL$81K
    1,500 sh
    		Nov 20, 2025Nov 21, 2025
    traded Nov 20, 2025
    		+1dSEC Form 4

    Evidence

    23
    HJ
    Holstein JensDirector
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$61K
    1,491 sh
    		Nov 20, 2025Nov 21, 2025
    traded Nov 20, 2025
    		+1dSEC Form 4

    Evidence

    23
    IN
    Intrator Michael NDirector, CEO and President, 10% Owner
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$15K
    197 sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    22
    LW
    Lloyd George W.EVP, Investments & CLO
    RPRXRoyalty Pharma plc
    Open-market sale · 10b5-1 plan
    		SELL$8,978
    230 sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    21
    HR
    Horn David R.PRESIDENT & CFO
    SEERSeer, Inc.
    Open-market sale
    		SELL$13K
    6,797 sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    21
    LW
    Lloyd George W.EVP, Investments & CLO
    RPRXRoyalty Pharma plc
    Open-market sale · 10b5-1 plan
    		SELL$181K
    4,628 sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    21
    SR
    Sinclair III Eric L. (Ric)Chief Business Officer
    WAYWaystar Holding Corp.
    Open-market sale · 10b5-1 plan
    		SELL$342K
    9,701 sh
    		Nov 20, 2025Nov 21, 2025
    traded Nov 20, 2025
    		+1dSEC Form 4

    Evidence

    21
    LP
    Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
    ELVNEnliven Therapeutics, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$268K
    12.0K sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    16
    MM
    Matsuda MasaruSee Remarks
    ARQTArcutis Biotherapeutics, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$44K
    1,561 sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    16
    MM
    Matsuda MasaruSee Remarks
    ARQTArcutis Biotherapeutics, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$28K
    989 sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    16
    KK
    Keough KelliEVP, GBUL, SIPS
    SOFISoFi Technologies, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$273K
    10.3K sh
    		Nov 20, 2025Nov 21, 2025
    traded Nov 20, 2025
    		+1dSEC Form 4

    Evidence

    16
    BS
    Baig SaqibChief Accounting Officer
    PTONPELOTON INTERACTIVE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$17K
    2,387 sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    15
    SA
    Shafer AndrewChief Cust Mkt & Brnd Officer
    GEVOGevo, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$9,937
    5,000 sh
    		Nov 20, 2025Nov 21, 2025
    traded Nov 20, 2025
    		+1dSEC Form 4

    Evidence

    15
    LP
    Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
    ELVNEnliven Therapeutics, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$11K
    492 sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    14
    DS
    Dutt SubirChief Sales Officer
    XMTRXometry, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$125K
    2,075 sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence

    11
    MJ
    McLay Kathryn J.Executive Vice President
    WMTWalmart Inc.
    Open-market sale · 10b5-1 plan
    		SELL$407K
    4,000 sh
    		Nov 19, 2025Nov 21, 2025
    traded Nov 19, 2025
    		+2dSEC Form 4

    Evidence